Guangzhou Baiyunshan Pharmaceutical Holdings (00874): Guangzhou Baiyunshan Pharmaceutical Holdings Bio has received the Macao Traditional Medicine Registration Certificate.

Guangzhou Baiyunshan Pharmaceutical Holdings (00874) announced that recently, Guangzhou Baiyunshan Pharmaceutical Holdings Bio-Products Co., Ltd. (hereinafter referred to as Guangzhou Baiyunshan Pharmaceutical Holdings Bio) within the scope of consolidation has received the "Drug Registration Certificate" issued by the Macao Special Administrative Region Government's Drug Regulatory Department. Guangzhou Baiyunshan Pharmaceutical Holdings Bio obtained the "Drug Registration Certificate" for the freeze-dried human rabies vaccine (Vero cells) issued by the National Medical Products Administration in December 2025, and related market access and sales work is progressing in an orderly manner. After obtaining the "Drug Registration Certificate" from the Macao Special Administrative Region Government's Drug Regulatory Department, the drug will be authorized by Guangzhou Baiyunshan Pharmaceutical Holdings Bio to Guangzhou Pharmaceutical International (Macao) for sales in the Macao region, which will help Guangzhou Baiyunshan Pharmaceutical Holdings Bio expand its overseas market business and enhance the market competitiveness of the company's products.